Cellectric Biosciences is thrilled to announce a successful fundraising round, securing $1,470,000 in investment to further its cutting-edge research and development. As a pioneering company committed to decoding the software of life, Cellectric harnesses advanced technology that revolutionizes the way we manipulate and process cell suspensions. With its patented dielectric filter technology, the company provides unparalleled specificity and throughput in the selective permeabilization and disintegration of targeted cell subsets through electromagnetic manipulation. This breakthrough approach not only enhances precision but also minimizes unspecific interference, setting Cellectric apart in the rapidly evolving field of biosciences.
The newly raised funds will be instrumental in accelerating the company's ongoing projects, particularly as Cellectric prepares to launch its innovative platform in various applications ranging from drug discovery to cellular therapies. These resources will fuel advancements in research and development, enhance capability for scalability, and support key hiring initiatives to build a robust team of experts dedicated to pushing the boundaries of cellular technology. In an era where precision and speed are paramount, Cellectric is poised to lead the charge in harnessing the potential embedded within our biological systems. The future of biomedicine hinges on the ability to manipulate life at a cellular level, and with this new round of funding, Cellectric Biosciences is one step closer to transforming this vision into reality.
